Target intelligence / Profile preview

Angiogenic factor with G-patch and FHA domains 1 pseudogene 9 (AGGF1P9)

Target: AGGF1P9
Molecular classification: Pseudogene, Processed pseudogene

Overview

AGGF1P9 is a processed pseudogene derived from the gene coding for Angiogenic factor with G-patch and FHA domains 1. Pseudogenes are segments of DNA similar to known genes but are generally non-functional due to disabling mutations or lack of regulatory elements. While pseudogenes do not encode proteins, they can have epigenetic or post-transcriptional effects as RNA molecules, such as competing for microRNA binding sites, which in turn can indirectly modulate expression of their parent gene (a function described in other pseudogenes, especially in cancer contexts)[1][4][5]. No direct evidence supports AGGF1P9 acting as a therapeutic target, biomarker, or being implicated in drug action; its relevance is limited to genomic annotation and possible yet unconfirmed regulatory RNA roles.

Other names: AGGF1P9Angiogenic factor with G-patch and FHA domains 1 pseudogene 9

Biological functions

Potential post-transcriptional regulatory roles via pseudogene RNA (may act as a “miRNA decoy” for its parent gene, though no direct evidence for AGGF1P9; this is inferred from the literature on pseudogenes generally)Other (no protein function, possible RNA-based effects)

Disease associations

Other (no direct evidence for disease involvement, but some pseudogenes modulate gene expression, implicated in cancer indirectly)

Beyond the preview

Go deeper on Angiogenic factor with G-patch and FHA domains 1 pseudogene 9 (AGGF1P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiogenic factor with G-patch and FHA domains 1 pseudogene 9 (AGGF1P9).

Explore the full profile